Search for: "Astrazeneca, L.P." Results 1 - 20 of 35
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2022, 6:00 am by Douglas J. Bucklin, Ph.D.
Cir. 2021) 2021-1729 AstraZeneca AB and AstracZeneca Pharmacueticals LP (AstraZeneca) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
28 Nov 2009, 8:32 am by John W. Arden
AstraZeneca Pharmaceuticals, L.P., CCH State Unfair Trade Practices Law ¶31,932. [read post]
10 May 2007, 10:44 pm
Plaintiffs have recently filed more than 350 product liability lawsuits against AstraZeneca Pharmaceuticals L.P., the maker of the anti-psychotic drug Seroquel. [read post]
8 Dec 2021, 8:52 am by Lawrence B. Ebert
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
7 Nov 2009, 1:42 am
AstraZeneca Pharmaceuticals, L.P., --- S.W.3d ----, 2009 Ark. 547, 2009 WL 3681868 (Ark.) [read post]
27 Feb 2012, 3:30 am
A district court in Mississippi remanded the action to state court holding that because the State is not a citizen for purposes of establishing diversity, the existence of the State as a real party in interest destroys subject matter jurisdiction pursuant to CAFA The State of Mississippi, through its Attorney General, brought a state court action against pharmaceutical companies AstraZeneca Pharmaceuticals, L.P., AstraZeneca, L.P., AstraZeneca… [read post]
12 Jul 2012, 11:21 am
AstraZeneca, L.P., et al, the plaintiff allegedly suffered debilitating complications from prolonged use of the company’s anti-psychotic medication Seroquel. [read post]
12 Jul 2012, 11:21 am
AstraZeneca, L.P., et al, the plaintiff allegedly suffered debilitating complications from prolonged use of the company’s anti-psychotic medication Seroquel. [read post]
10 Feb 2012, 10:56 am by Courtney Minick
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
10 Feb 2012, 10:56 am by Courtney Minick
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
17 Jan 2007, 5:24 am
.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
15 Sep 2010, 12:14 pm by Anna Christensen
United StatesDocket: 10-150Issue(s): Whether a court of appeals has jurisdiction to review a federal prisoner’s motion based on newly discovered evidence that the prisoner is mentally retarded and therefore constitutionally ineligible for execution, even if that evidence does not negate the prisoner’s guilt.Certiorari-Stage DocumentsOpinion below (5th Circuit)Petition for certiorariAmicus brief for Advocates for Human Rights Today’s second petition of the day is: Title: Sprint… [read post]
9 Nov 2009, 10:29 am by Beck/Herrmann
AstraZeneca Pharmaceuticals, L.P., slip op. [read post]
25 Aug 2010, 12:37 am by Kelly
(Patent Docs) Clobex (Clobetasol propionate) – US: Patent infringement complaint filed following a Paragraph IV certification: Galderma Laboratories, L.P. et al. v. [read post]
3 Oct 2015, 4:13 pm by admin
AstraZeneca Pharm., L.P., 958 So. 2d 1054, 1056 (Fla. 3d DCA 2007). [read post]